Completed PHASE2 INTERVENTIONAL 4-arm NCT00218608

Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone

Disulfiram for Cocaine Abuse in Methadone- Patients

Sponsor: University of Arkansas

Conditions Cocaine-Related Disorders Opioid-Related Disorders

Interventions Disulfiram

Updated 5 times since 2017 Last updated: Jan 26, 2012 Started: Apr 30, 2001 Primary completion: Jan 31, 2007 Completion: Jan 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cocaine-Related Disorders and Opioid-Related Disorders, this trial is completed. The trial is conducted by University of Arkansas and has accumulated 5 data snapshots since 2001. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Arkansas
Yale University

Data source: University of Arkansas

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Little Rock, United States